Cargando…

M(6)A Modifier-Mediated Methylation Characterized by Diverse Prognosis, Tumor Microenvironment, and Immunotherapy Response in Hepatocellular Carcinoma

OBJECTIVE: Emerging evidence highlights the clinical implications of N(6)-methyladenosine (m(6)A) modification in HCC. Yet, the roles of m(6)A modification in modulating cancer immunity and shaping tumor microenvironment (TME) are undefined in hepatocellular carcinoma (HCC). METHODS: Here, m(6)A mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fei, Zhang, Xinyue, Liu, Ziyu, Cai, Weiye, Song, Chao, Jiang, Yan, Yin, Ji, Liu, Zongchao, Huang, Chenyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398803/ https://www.ncbi.nlm.nih.gov/pubmed/36016585 http://dx.doi.org/10.1155/2022/2513813

Ejemplares similares

An in‐depth analysis of the immunomodulatory mechanisms of intervertebral disc degeneration
por: Song, Chao, et al.
Publicado: (2022)

Resveratrol induces proliferation and differentiation of mouse pre-osteoblast MC3T3-E1 by promoting autophagy
por: Cai, Weiye, et al.
Publicado: (2023)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

m(6)A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma
por: Chen, Lianze, et al.
Publicado: (2021)

Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy
por: Zhao, Kun, et al.
Publicado: (2022)

Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma
por: Yin, Tengfei, et al.
Publicado: (2022)

Shared mechanisms and crosstalk of COVID-19 and osteoporosis via vitamin D
por: Liu, Fei, et al.
Publicado: (2022)

Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer
por: Zhao, Hongying, et al.
Publicado: (2023)

Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment
por: Zhang, Fa-Peng, et al.
Publicado: (2020)

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
por: Bian, Zichen, et al.
Publicado: (2022)

A review of Duhuo Jisheng decoction mechanisms in intervertebral disc degeneration in vitro and animal studies
por: Zhou, Daqian, et al.
Publicado: (2023)

The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma
por: Qin, Sha, et al.
Publicado: (2022)

A scoring model based on ferroptosis genes for prognosis and immunotherapy response prediction and tumor microenvironment evaluation in liver hepatocellular carcinoma
por: Gao, Lei, et al.
Publicado: (2021)

Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
por: Xu, Yan, et al.
Publicado: (2022)

Immune Microenvironment Characteristics of Urachal Carcinoma and Its Implications for Prognosis and Immunotherapy
por: Zhang, Xinke, et al.
Publicado: (2022)

Comprehensive Analysis of N6-Methyladenosine (m(6)A) RNA Methylation Regulators and Tumour Microenvironment Cell Infiltration Involving Prognosis and Immunotherapy in Gastroesophageal Adenocarcinomas
por: Liu, Duanrui, et al.
Publicado: (2022)

Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma
por: Zheng, Ju-Yan, et al.
Publicado: (2022)

Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
por: Feng, Hai, et al.
Publicado: (2022)

Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
por: Zeng, Weiwei, et al.
Publicado: (2022)

The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
por: Guizhen, Zhang, et al.
Publicado: (2022)

5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma
por: Liu, Taisheng, et al.
Publicado: (2022)

Guanylate‐binding proteins signature predicts favorable prognosis, immune‐hot microenvironment, and immunotherapy response in hepatocellular carcinoma
por: Ning, Yumei, et al.
Publicado: (2023)

Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer
por: Guo, Yongdong, et al.
Publicado: (2021)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

m(6)A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma
por: Xiao, Zhenyong, et al.
Publicado: (2023)

Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
por: Zhao, Ming, et al.
Publicado: (2023)

Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients
por: Huang, Shenglan, et al.
Publicado: (2021)

A macropinocytosis-related gene signature predicts the prognosis and immune microenvironment in hepatocellular carcinoma
por: Ding, Xinjiang, et al.
Publicado: (2023)

A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy
por: Chen, Erbao, et al.
Publicado: (2023)

Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment
por: Kershaw, Michael H, et al.
Publicado: (2013)

m6A Regulator-Mediated RNA Methylation Modification Patterns are Involved in the Pathogenesis and Immune Microenvironment of Depression
por: Wang, Ye, et al.
Publicado: (2022)

Role of m(5)C RNA methylation regulators in colorectal cancer prognosis and immune microenvironment
por: Fang, Xiaojie, et al.
Publicado: (2022)

Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy
por: Liu, Zezhen, et al.
Publicado: (2021)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Comprehensive Analysis of Cellular Senescence-Related Genes in Prognosis, Molecular Characterization and Immunotherapy of Hepatocellular Carcinoma
por: Sun, Liang, et al.
Publicado: (2022)

Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration
por: Yue, Qingfang, et al.
Publicado: (2022)

Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma
por: Pan, Long, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pfkpq5chg8oe4rbcj58ba05tb8